Fig. 7: Kaplan-Meier (KM) curves for different risk groups in the non-TCGA datasets during external-cross-dataset validation. | npj Precision Oncology

Fig. 7: Kaplan-Meier (KM) curves for different risk groups in the non-TCGA datasets during external-cross-dataset validation.

From: Autosurv: interpretable deep learning framework for cancer survival analysis incorporating clinical and multi-omics data

Fig. 7

KM curves for the high-risk (\({\rm{PI}} > {{\rm{PI}}}_{{\rm{med}}}^{{\rm{TCGA}}}\)) and low-risk (\({\rm{PI}}\le {{\rm{PI}}}_{{\rm{med}}}^{{\rm{TCGA}}}\)) patient groups in the non-TCGA datasets. a BRCA: KM curves for patients in the Caldas-BC dataset, with \({{\rm{PI}}}_{{\rm{med}}}^{{\rm{TCGA}}}\) derived from the TCGA-BRCA dataset; b OV: KM curves for patients in the ICGC-OVAU dataset, with \({{\rm{PI}}}_{{\rm{med}}}^{{\rm{TCGA}}}\) derived from the TCGA-OV dataset.

Back to article page